The Pfizer(Fizer) vaccine announcement is ebbing away, but the harsh reality is beginning. Pfizer(pronounced fizer) and BioNTech expect to seek emergency approval from the U.S. Food and Drug Administration to begin distributing their COVID-19 vaccine before releasing new data showing the vaccine is about 95% effective, the company said Wednesday.
Pfizer (Fizer) and BioNTECH plan to apply with the FDA within days based on the safety and efficacy data collected to date and production data regarding vaccine quality and consistency, according to a press release from both companies. The U.K. has already approved Pfizer( Fizer) as a covid-19 vaccine.
Health officials in Iowa say they expect shipments of Pfizer( Fizer)’s BioNTech vaccine to begin once the FDA gives its approval. Fortunately, the US Centers for Disease Control and Prevention (CDC) says it is ready and able to store Pfiser’s vaccine.
The vaccine from the U.S. biotech company Moderna is based on a new messenger RNA technology (mRNA). Pfizer( fizer) and its German partner BioNTech have announced positive results from their study of the human papillomavirus (HPV) vaccine in the United States. They are presenting soon at the American Society for Immunology (ASI) annual meeting in San Diego, California.
The pharmaceutical giant will deliver 40 million doses to regulators who have approved the vaccine for clinical trials, which Pfizer CEO Albert Bourla expects by the end of this year.
Rival Merck is also working on a coronavirus vaccine but is in an early stage compared to Pfizer. Merck might provide some important updates before the end of the year.
Pizer said it would immediately begin shipping a limited supply to the U.K. and prepare for even wider distribution if the U.S. Food and Drug Administration makes a similar decision, with a decision expected as early as next week.